In humans, it has been observed that in some solid tumors (e.g., lung cancers, breast cancers, head and neck epithelial cancers), there is a greater expression of NOD1 and NOD2 on tumor cells and greater polymorphism for NOD2 [14,158]. Here, NOD2 is linked to breast carcinoma.